600976.SS

Jianmin Pharmaceutical Group Co.,Ltd. [600976.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600976.SS Stock Summary

Top 10 Correlated Stocks

600976.SS


In the News

600976.SS Financial details

Company Rating
Strong Buy
Market Cap
8.17B
Income
521.46M
Revenue
4.21B
Book val./share
14.69
Cash/share
6.53
Dividend
1
Dividend %
1.6%
Employees
2.25K
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
19.1
Forward P/E
11.64
PEG
6.57
P/S
2.48
P/B
4.44
P/C
8.8
P/FCF
85.95
Quick Ratio
1.29
Current Ratio
1.5
Debt / Equity
0.22
LT Debt / Equity
0.01
-
-
EPS (TTM)
3.42
EPS next Y
4.94
EPS next Q
-
EPS this Y
28.68%
EPS next Y
44.52%
EPS next 5Y
76.32%
EPS last 5Y
41.55%
Revenue last 5Y
13.32%
Revenue Q/Q
13.85%
EPS Q/Q
-34.58%
-
-
-
-
SMA20
-1.86%
SMA50
-15.03%
SMA100
-7.65%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
25%
ROC
0.27%
Gross Margin
47%
Oper. Margin
15%
Profit Margin
13%
Payout
31%
Shs Outstand
153M
Shs Float
105.53M
-
-
-
-
Target Price
-
52W Range
42.24-84.93
52W High
-31.56%
52W Low
+36.88%
RSI
57.11
Rel Volume
1.12
Avg Volume
2.43M
Volume
2.72M
Perf Week
5.06%
Perf Month
5.87%
Perf Quarter
-
Perf Half Y
-9.28%
-
-
-
-
Beta
0.662
-
-
Volatility
1.52%, 1.51%
Prev Close
3.03%
Price
57.49
Change
9.09%

600976.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
14.6816.0221.5923.9127.36
Net income per share
0.60.962.012.683.41
Operating cash flow per share
0.490.821.711.422.43
Free cash flow per share
0.030.521.340.972.01
Cash per share
3.123.765.515.656.54
Book value per share
7.888.5910.2812.2314.7
Tangible book value per share
7.658.3510.0411.9914.65
Share holders equity per share
7.888.5910.2812.2314.7
Interest debt per share
0.350.130.40.383.31
Market cap
2.71B3.89B11.98B7.57B10.07B
Enterprise value
2.62B3.82B11.74B7.4B10.26B
P/E ratio
29.6226.3439.2518.5419.3
Price to sales ratio
1.211.593.652.082.41
POCF ratio
36.431.0146.2335.0527.09
PFCF ratio
527.6848.6958.9651.1632.78
P/B Ratio
2.262.967.674.064.48
PTB ratio
2.262.967.674.064.48
EV to sales
1.171.563.582.032.45
Enterprise value over EBITDA
20.521.0129.4614.2627.6
EV to operating cash flow
35.1630.4445.2934.2827.61
EV to free cash flow
509.7547.857.7850.0433.42
Earnings yield
0.030.040.030.050.05
Free cash flow yield
00.020.020.020.03
Debt to equity
0.040.020.040.030.22
Debt to assets
0.030.010.020.020.12
Net debt to EBITDA
-0.72-0.39-0.61-0.320.53
Current ratio
1.681.421.521.51.49
Interest coverage
157.65293.66112.7291.9464.87
Income quality
0.80.840.80.530.71
Dividend Yield
0.010.0100.020.02
Payout ratio
0.340.210.190.30.29
Sales general and administrative to revenue
0.010.010.010.010.01
Research and developement to revenue
0.020.020.020.020.02
Intangibles to total assets
0.020.020.020.010.01
Capex to operating cash flow
-0.93-0.36-0.22-0.31-0.17
Capex to revenue
-0.03-0.02-0.02-0.02-0.02
Capex to depreciation
-3.55-2.2-1.95-1.75-1.09
Stock based compensation to revenue
0.010.0100-0.05
Graham number
10.3113.6521.5627.1633.58
ROIC
0.080.110.20.210.1
Return on tangible assets
0.050.060.110.120.13
Graham Net
1.560.741.781.621.64
Working capital
472.36M445.44M633.41M771.06M908.95M
Tangible asset value
1.17B1.28B1.52B1.83B2.24B
Net current asset value
450.07M419.18M596.12M734.91M873.04M
Invested capital
0.040.020.040.030.22
Average receivables
510.2M620.35M731M903.4M1.13B
Average payables
219.27M306.49M374.08M491.68M507.21M
Average inventory
147.61M181.73M225.37M292.31M406.86M
Days sales outstanding
90.06102.2986.15103.57106.8
Days payables outstanding
64.3694.173.35107.9963.94
Days of inventory on hand
36.557.3343.6964.1371.47
Receivables turnover
4.053.574.243.523.42
Payables turnover
5.673.884.983.385.71
Inventory turnover
106.378.355.695.11
ROE
0.080.110.20.220.23
Capex per share
-0.45-0.3-0.37-0.45-0.42

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.556.627.526.297.12
Net income per share
0.530.6511.070.69
Operating cash flow per share
0.530.650.980.610.65
Free cash flow per share
0.360.570.870.540.49
Cash per share
5.647.025.66.056.53
Book value per share
12.2212.8212.9114.0514.69
Tangible book value per share
11.9712.5712.6613.8214.65
Share holders equity per share
12.2212.8212.9114.0514.69
Interest debt per share
0.360.710.810.843.28
Market cap
7.58B11.71B11.76B10.07B10.07B
Enterprise value
7.41B11.45B11.49B10.07B10.27B
P/E ratio
23.2629.4119.2415.4723.68
Price to sales ratio
8.9611.5610.2510.539.25
POCF ratio
93.02117.6379.03107.9100.8
PFCF ratio
137.04134.3288.6123.6133.01
P/B Ratio
4.075.965.974.724.48
PTB ratio
4.075.965.974.724.48
EV to sales
8.7611.310.0110.539.43
Enterprise value over EBITDA
55.49112.7563.164.7147.03
EV to operating cash flow
90.98115.0477.17107.92102.76
EV to free cash flow
134.04131.3786.52123.62135.6
Earnings yield
0.010.010.010.020.01
Free cash flow yield
0.010.010.010.010.01
Debt to equity
0.030.060.060.060.22
Debt to assets
0.020.030.030.030.12
Net debt to EBITDA
-1.24-2.53-1.520.012.81
Current ratio
1.51.641.471.51.49
Interest coverage
102.362.4K202.7128.6637.1
Income quality
110.970.570.94
Dividend Yield
000.0100.02
Payout ratio
0.01010.011.44
Sales general and administrative to revenue
-0.080.04-0.020.12-0.09
Research and developement to revenue
0.030.020.020.020.02
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
-0.32-0.12-0.11-0.13-0.24
Capex to revenue
-0.03-0.01-0.01-0.01-0.02
Capex to depreciation
-1.57-0.96-1.250.66-1.45
Stock based compensation to revenue
0.010000
Graham number
12.1213.6917.0618.415.16
ROIC
0.070.050.070.070.02
Return on tangible assets
0.020.030.040.040.03
Graham Net
1.623.221.591.871.64
Working capital
771.06M1.06B790.73M859.98M908.95M
Tangible asset value
1.83B1.92B1.93B2.1B2.24B
Net current asset value
734.91M1.02B749.53M806.38M873.04M
Invested capital
0.030.060.060.060.22
Average receivables
1.09B1.14B1.26B1.28B1.26B
Average payables
578.13M611.68M596.63M596.85M508.04M
Average inventory
270.15M355.02M325.93M317.44M390.51M
Days sales outstanding
109.92111.3599.1122.01101.21
Days payables outstanding
118.56108.0280.68113.1156.93
Days of inventory on hand
70.4161.2442.3160.9563.63
Receivables turnover
0.820.810.910.740.89
Payables turnover
0.760.831.120.81.58
Inventory turnover
1.281.472.131.481.41
ROE
0.040.050.080.080.05
Capex per share
-0.17-0.08-0.11-0.08-0.16

600976.SS Frequently Asked Questions

What is Jianmin Pharmaceutical Group Co.,Ltd. stock symbol ?

Jianmin Pharmaceutical Group Co.,Ltd. is a CN stock and trading under the symbol 600976.SS

What is Jianmin Pharmaceutical Group Co.,Ltd. stock quote today ?

Jianmin Pharmaceutical Group Co.,Ltd. stock price is $57.49 today.

Is Jianmin Pharmaceutical Group Co.,Ltd. stock public?

Yes, Jianmin Pharmaceutical Group Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap